| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $591K | +31.0% |
| SG&A Expense | $11.9M | +6.4% |
| Operating Income | -$16.5M | -41.2% |
| Pre-tax Income | -$14.0M | -34.1% |
| Income Tax | $106K | +106.0% |
| Net Income | -$7.0M | -108.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.2M | +200.4% |
| Accounts Receivable | $145K | -35.9% |
| Current Assets | $57.9M | +187.1% |
| Total Assets | $60.2M | +155.6% |
| Current Liabilities | $2.1M | -25.3% |
| Total Liabilities | $2.1M | -26.9% |
| Stockholders' Equity | $58.1M | +181.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.9M | -0.1% |
| Capital Expenditures | $7.7M | +201.4% |
| Investing Cash Flow | -$2.4M | -179.1% |
| Financing Cash Flow | $49.4M | — |
| Free Cash Flow | -$16.6M | -45.0% |